• Have a question?
    Open from 8am to 7pm Monday to Friday
    Call customer services
    0345 54 32 600

EDX Medical Group Plc (EDX)

Sell: 12.50p|Buy: 14.50p|Change: 0 (0%)
This investment is listed on the Aquis Stock Exchange. Investments on this market tend to be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

Company profile

EDX Medical Group PLC is principally engaged in the business of creating innovative health testing solutions and developing biological and digital technologies to improve the detection of diseases and disorders. It develops and provides digital diagnostic products and services for testing in areas including cancer, cardiovascular disease, neurology, and infectious diseases. It operates a molecular biology and diagnostics laboratory in Cambridge, UK, from which it performs research & development, and provides testing and genomic sequencing services. It has two operating segments: Medical goods and Medical services. The majority of revenue is generated from the Medical goods segment. Geographically, all revenue was derived from the United Kingdom.

Address





Sector 

Healthcare


Forecast key dates

NameKey Date

Previous key dates

NameKey Date

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.